StonvexLoading…
StonvexCore line items from TPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $732.22M | $521.39M | $3.47B | $2.50B | $1.64B |
Operating Income | Not available | $5.62M | $301.81M | $222.56M | $153.59M |
Net Income | Not available | $6.79M | $241.09M | $180.93M | $124.78M |
EPS (Diluted) | $0.45 | $0.08 | $2.72 | $2.02 | $1.38 |
Total Assets | Not available | $4.96B | $4.98B | $4.99B | $4.80B |
Total Liabilities | Not available | $1.66B | $1.66B | $1.69B | $1.51B |
Cash & Equivalents | Not available | $847.90M | $982.81M | $791.96M | $622.64M |
Free Cash Flow OCF − CapEx | Not available | $-54.68M | $128.54M | $-84.63M | $-123.71M |
Shares Outstanding | Not available | 85.14M | 84.48M | 85.99M | 87.51M |